Alvarez-Larran, A., Garrote, M., Ferrer-Marin, F., Perez-Encinas, M., Mata-Vazquez, M., Bellosillo, B., . . . Pereira, A. (2022). Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. WILEY.
Citación estilo ChicagoAlvarez-Larran, A., et al. Real-world Analysis of Main Clinical Outcomes in Patients With Polycythemia Vera Treated With Ruxolitinib or Best Available Therapy After Developing Resistance/intolerance to Hydroxyurea. WILEY, 2022.
Cita MLAAlvarez-Larran, A., et al. Real-world Analysis of Main Clinical Outcomes in Patients With Polycythemia Vera Treated With Ruxolitinib or Best Available Therapy After Developing Resistance/intolerance to Hydroxyurea. WILEY, 2022.